Vetter, Richard J., Ph.D.

From:
rvetter@mayo.edu
To:
PCa Support Group
Cc:
Frey, Laura J.

Fri, Sep 5 at 1:23 PM

Dear Support Group Members,
Our next meeting will be held at noon (CDT) on Wednesday September 10 in Baldwin 1-507. Our speaker will be Geoffrey Johnson, MD, PhD, Head of Mayo Clinic Nuclear Medicine. Dr. Johnson will present "Update on Pluvicto/PSMA Therapy." Pluvicto is a radioactive drug used to treat PSMA-positive metastatic castration resistent prostate cancer in men already treated with hormone therapy or hormone therapy and chemotherapy.
If you are unable to attend in person, you are encouraged to connect to the meeting via Zoom using the following link:

Join Zoom Meeting
https://mc-meet.zoom.us/j/98297582853?pwd=DKeXLP28QtPvrlubzzOXljZm4uQbk3.1
This Zoom link is good for all 2025 meetings except the December social.
Hoping to see you next week,
Dick

Richard J. Vetter, PhD
Professor Emeritus
Mayo Clinic
Rochester, MN 55905